Phillip Ross, MD
Urology · Oakland, CANPI 1033220611
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,080 of the $2,388 with a category attached, or 87.1%. 6 manufacturers reported payments, led by Teleflex LLC at 54.9% of the total. Reporting peaked in 2021 at $1,314 and has fallen 97.3% since, to $35 in 2025. That places this record below the midpoint for urology clinicians in CA, where the typical reported total is $2,485.
Across 15 payments — averaging $159.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$1K
- Boston Scientific$965
- Intuitive Surgical$61
- AstraZeneca$35
- AbbVie$14
- Travere Therapeutics, Inc.$3
What the payments were for
- Travel & lodging$2,08087%
- Food & beverage$27011%
- Education$382%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 5 | $1,311 |
| Boston Scientific | 5 | $965 |
| Intuitive Surgical | 1 | $61 |
| AstraZeneca | 1 | $35 |
| AbbVie | 1 | $14 |
| Travere Therapeutics, Inc. | 2 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift System$1,217
- SPACEOAR$785
How this compares
$2,388 in reported general payments places this provider in the 45th percentile of 1,324 urology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 108 | $92,398 |
| Tamsulosin Hcl | 678 | $14,266 |
| Methenamine Hippurate | 40 | $4,193 |
| Finasteride | 229 | $3,895 |
| Testosterone | 33 | $2,875 |
| Cefpodoxime Proxetil | 61 | $2,358 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 96 | $2,305 |
| Dutasteride | 13 | $1,579 |
| Fosfomycin Tromethamine | 12 | $995 |
| Estradiol | 13 | $894 |
| Tadalafil | 26 | $893 |
| Cephalexin | 121 | $677 |
| Sildenafil Citrate | 19 | $248 |
| Gabapentin | 23 | $183 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $183 |
Paid to pharmacies, not to this prescriber.
Other urology in Oakland
- Chih Hsin WenOakland$80K
- Stephen FreedlandWest Hollywood$1.9M
- Arie BelldegrunLos Angeles$1.8M
- Mihir DesaiLos Angeles$1.5M
- Steven WilsonIndio$1.1M
- Stuart HoldenLos Angeles$1.1M
- Elward CrawfordSan Diego$849K
- Edward UchioOrange$849K
- Victor ChingUpland$809K
- Jaime LandmanOrange$657K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.